Amlodipine
Long-acting dihydropyridine calcium channel blocker supplied as besylate salt — USP/EP/BP grade — for oral tablet manufacturing. Sourced for hypertension and chronic stable angina formulation lines.
Pharmaceutical & Life Science Solutions
ACE inhibitors, angiotensin receptor blockers, and calcium channel antagonists for blood pressure regulation. Supplied in USP/EP/BP grade for oral solid-dose manufacturing across global cardiovascular product lines.
Long-acting dihydropyridine calcium channel blocker supplied as besylate salt — USP/EP/BP grade — for oral tablet manufacturing. Sourced for hypertension and chronic stable angina formulation lines.
First-generation ACE inhibitor in USP/EP/BP grade for oral tablet manufacturing. Sourced for hypertension, heart failure, and post-myocardial infarction formulation lines.
ACE inhibitor prodrug salt in USP/EP/BP grade for oral tablet manufacturing. Sourced for hypertension, heart failure, and asymptomatic left ventricular dysfunction protocols.
Angiotensin II receptor blocker in USP/EP/BP grade for oral tablet manufacturing. Sourced for hypertension and diabetic nephropathy formulation lines.
Non-prodrug ACE inhibitor in USP/EP/JP grade for oral tablet manufacturing. Sourced for hypertension, heart failure, and post-MI cardioprotective formulation lines.
Selective AT1 angiotensin receptor antagonist in USP/EP/BP grade for oral tablet manufacturing. Sourced for hypertension and diabetic nephropathy formulation lines.
Central alpha-2 adrenergic agonist in USP/EP/BP grade for oral tablet and suspension manufacturing. Sourced for hypertension management, notably pregnancy-induced hypertension formulations.
Highly selective beta-1 blocker with vasodilatory activity, supplied as hydrochloride salt — USP grade — for oral tablet manufacturing. Sourced for hypertension formulation lines requiring nitric-oxide-mediated vasodilation.
ACE inhibitor prodrug in USP/EP/BP grade for oral capsule manufacturing. Sourced for hypertension, heart failure, and post-MI cardiovascular risk reduction formulation lines.
Long-acting angiotensin II receptor blocker in USP/EP/BP grade for oral tablet manufacturing. Sourced for hypertension formulation lines requiring extended 24-hour blood pressure control.
Non-peptide angiotensin II receptor blocker in USP/EP/BP grade for oral tablet manufacturing. Sourced for hypertension, post-MI heart failure, and renal protection formulation lines.
Phenylalkylamine calcium channel blocker supplied as hydrochloride salt — USP/EP/BP grade — for oral tablet and solution manufacturing. Sourced for hypertension, angina, and supraventricular tachycardia formulation lines.